MedPath

Promethazine Hydrochloride

Promethazine Hydrochloride

Approved
Approval ID

7834998b-2c53-4edc-97d9-508f7cc92f7c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 22, 2023

Manufacturers
FDA

Marlex Pharmaceuticals Inc

DUNS: 782540215

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

promethazine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10135-495
Application NumberANDA091179
Product Classification
M
Marketing Category
C73584
G
Generic Name
promethazine hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 22, 2023
FDA Product Classification

INGREDIENTS (4)

LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
PROMETHAZINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: R61ZEH7I1I
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Promethazine Hydrochloride - FDA Drug Approval Details